[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-339133-105":59,"doc-detail-339133-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","population-based-brca-germline-mutation-screening-in-the-han-chinese-identifies-individuals-at-risk-experience-from-a-clinical-diagnostic-center-from-greater-shanghai-area","Population-based BRCA germline mutation screening in the Han Chinese identifies individuals at risk of BRCA mutation-related cancer - experience from a clinical diagnostic center from greater Shanghai area","","Background: Deleterious BRCA1/2 (BRCA) germline mutations increase risk of BRCA mutation-related malignancies including breast, ovarian, prostate, and pancreatic cancer. Germline BRCA variation shows substantial ethnic diversity, yet evidence for Chinese Han remains limited, limiting development of BRCA screening strategies. Methods: BRCA mutational spectrum (SNVs, indels, and large genomic rearrangements) was profiled in 2,080 healthy Han individuals and 522 patients. Incident events were monitored in 1,005 participants from the healthy group. Results: The Han population showed a distinct spectrum with 0.53% PLP prevalence and 3 LGR cases; BRCA1 c.5470_5477del was common in North Han. None of the LGR carriers developed cancer during follow-up; relative risk for PLP carriers vs PLP-free was 135.55. Conclusion: These findings support standardized population-based screening to improve prevention and care. Further multicenter prospective studies are needed.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/population-based-brca-germline-mutation-screening-in-the-han-chinese-identifies-individuals-at-risk-experience-from-a-clinical-diagnostic-center-from-greater-shanghai-area/339133/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/population-based-brca-germline-mutation-screening-in-the-han-chinese-identifies-individuals-at-risk-experience-from-a-clinical-diagnostic-center-from-greater-shanghai-area/339133.png","ImageObject",300,407,{"name":92,"@type":93},"Olivia Brown","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What did the study aim to determine in the Chinese Han population?","Question",{"text":112,"@type":113},"It profiled the BRCA mutational spectrum in healthy Han individuals and BRCA mutation-related cancer patients to characterize the Chinese Han BRCA genetic background, especially East Han.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What types of BRCA genetic variations were analyzed?",{"text":117,"@type":113},"The study assessed single nucleotide variants, insertion/deletion changes, and large genomic rearrangements (LGR) in participants.",{"name":119,"@type":110,"acceptedAnswer":120},"What were the key findings about cancer risk in BRCA pathogenic/likely pathogenic carriers?",{"text":121,"@type":113},"Among monitored healthy participants, none of the LGR carriers developed cancer during follow-up, and BRCA PLP carriers had a markedly higher risk of BRCA mutation-related cancers than PLP-free individuals, with a reported relative risk of 135.55.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},339133,1790694314,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},16904993612988,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Wu et al. BMC Cancer (2024) 24:411 BMC Cancer  \n[https://doi.org/10.1186/s12885-024-12089-w](https://doi.org/10.1186/s12885-024-12089-w)  \nRESEARCH Open Access  \nPopulation-based BRCA germline mutation screening in the Han Chinese identifies individuals at risk of BRCA mutation-related cancer: experience from a clinical diagnostic center from greater Shanghai area  \nZhiyuan Wu 1†, Qingyun Zhang2†, Yiting Jin3†, Xinju Zhang2, Yanli Chen 1, Can Yang 1, Xuemei Tang2, Haowen Jiang4, Xiaoyi Wang5, Xinli Zhou6, Feng Yu7, Bing Wang7* and Ming Guan 1,2*  \nAbstract  \nBackground Deleterious BRCA1/2 (BRCA) mutation raises the risk for BRCA mutation-related malignancies, including breast, ovarian, prostate, and pancreatic cancer. Germline variation of BRCA exhibits substantial ethnical diversity. However, there is limited research on the Chinese Han population, constraining the development of strategies for BRCA mutation screening in this large ethnic group.  \nMethods We profile the BRCA mutational spectrum, including single nucleotide variation, insertion/deletion, and large genomic rearrangements in 2,080 apparently healthy Chinese Han individuals and 522 patients with BRCA mutation-related cancer, to determine the BRCA genetic background of the Chinese Han population, especially of the East Han. Incident cancer events were monitored in 1,005 participants from the healthy group, comprising 11 BRCA pathogenic/likely pathogenic (PLP) variant carriers and 994 PLP-free individuals, including 3 LGR carriers.  \nResults Healthy Chinese Han individuals demonstrated a distinct BRCA mutational spectrum compared to cancer patients, with a 0. 53%(1 in 189) prevalence of pathogenic/likely pathogenic (PLP) variant, alongside a 3 in 2,080 occurrence of LGR. BRCA1 c. 5470_ 5477del demonstrated high prevalence (0 .44%) in the North Han Chinese and penetrance for breast cancer. None of the 3 LGR carriers developed cancer during the follow-up. We calculated a relative risk of 135.55 (95% CI 25.07 to 732. 88) for the development of BRCA mutation-related cancers in the BRCA PLP variant carriers (mean age 42.91 years, median follow-up 10 months) compared to PLP-free individuals (mean age 48.47 years, median follow-up 16 months) .  \n†Zhiyuan Wu, Qingyun Zhang andYiting Jin contributed equally to this work.  \n*Correspondence:  \nBing Wang [bingbing1967@sina.com](bingbing1967@sina.com)[ ](bingbing1967@sina.com)Ming Guan [guanming88@yahoo.com](guanming88@yahoo.com)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/l](http://creativecommons.org/l)icenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ([http://creativecommons.org/publicdomain/zero/1.0/](http://creativecommons.org/publicdomain/zero/1.0/)) applies to the data made available in this article, unless otherwise stated in a credit line to the data.  \nConclusion The unique BRCA mutational profile in the Chinese Han highlights the potential for standardized population-based BRCA variant screening to enhance BRCA mutation-related cancer prevention and treatment. Key message of article  \nThere is significant ethnical diversity in ","cbCaikFypGRsapSj","https://ap.wps.com/l/cbCaikFypGRsapSj","pdf",2670974,13,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Introduction","[{\"question\":\"What did the study aim to determine in the Chinese Han population?\",\"answer\":\"It profiled the BRCA mutational spectrum in healthy Han individuals and BRCA mutation-related cancer patients to characterize the Chinese Han BRCA genetic background, especially East Han.\"},{\"question\":\"What types of BRCA genetic variations were analyzed?\",\"answer\":\"The study assessed single nucleotide variants, insertion/deletion changes, and large genomic rearrangements (LGR) in participants.\"},{\"question\":\"What were the key findings about cancer risk in BRCA pathogenic/likely pathogenic carriers?\",\"answer\":\"Among monitored healthy participants, none of the LGR carriers developed cancer during follow-up, and BRCA PLP carriers had a markedly higher risk of BRCA mutation-related cancers than PLP-free individuals, with a reported relative risk of 135.55.\"}]","Population-based BRCA germline mutation screening in the Han Chinese identifies individuals at risk of BRCA mutation-related cancer - experience from a clinical diagnostic center from greater Shanghai area | PDF",1790028133,33,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/41b92864b1c87e879fe78876ff0c5cae.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9f705def7e0abfb595130e412a050f2f.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7bbf55049c19bb5d51e9d23e17883d9d.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ba336d0dc41386f7725c6857100b2c73.webp",980,1306]